Benign recurrent intrahepatic cholestasis - 2 (BRIC-2)/ABCB11 deficiency in a young child – Report from a tertiary care center in South India

ABCB11 deficiency, formerly benign recurrent intrahepatic cholestasis (BRIC) is a very rare hereditary disorder characterized by the recurrent and intermittent episodes of cholestasis, jaundice, and pruritus. We report the case of a 12-year-old boy presenting with recurrent episodes of jaundice and...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: K V Kalaranjini, Jinu A Glaxon, Sheela Vasudevan, M L Arunkumar
Formato: article
Lenguaje:EN
Publicado: Wolters Kluwer Medknow Publications 2021
Materias:
Acceso en línea:https://doaj.org/article/0c72f70da8ce45fc8385a256521a78b7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0c72f70da8ce45fc8385a256521a78b7
record_format dspace
spelling oai:doaj.org-article:0c72f70da8ce45fc8385a256521a78b72021-12-02T19:23:04ZBenign recurrent intrahepatic cholestasis - 2 (BRIC-2)/ABCB11 deficiency in a young child – Report from a tertiary care center in South India0377-492910.4103/IJPM.IJPM_254_20https://doaj.org/article/0c72f70da8ce45fc8385a256521a78b72021-01-01T00:00:00Zhttp://www.ijpmonline.org/article.asp?issn=0377-4929;year=2021;volume=64;issue=5;spage=146;epage=148;aulast=Kalaranjinihttps://doaj.org/toc/0377-4929ABCB11 deficiency, formerly benign recurrent intrahepatic cholestasis (BRIC) is a very rare hereditary disorder characterized by the recurrent and intermittent episodes of cholestasis, jaundice, and pruritus. We report the case of a 12-year-old boy presenting with recurrent episodes of jaundice and severe pruritis since childhood. An extensive workup was done to rule out all the possible etiologies. Liver biopsy was done and histopathology was consistent with intrahepatic cholestasis. Immunohistochemistry, enzyme studies, and genetic testing confirmed the diagnosis. The patient was treated with Ursodeoxycholicacid and is on regular follow-up. We report this case due to the rarity of the disease in South India and to highlight the importance of genetic testing, which is the gold standard for diagnosis as well as for the classification of the disease. These patients should be under regular follow-up as those with fibrosis progression are at a risk for cholangiocarcinoma and hepatocellular carcinoma.K V KalaranjiniJinu A GlaxonSheela VasudevanM L ArunkumarWolters Kluwer Medknow Publicationsarticleabcb11benign recurrent intrahepatic cholestasischolestasiscirrhosisjaundicePathologyRB1-214MicrobiologyQR1-502ENIndian Journal of Pathology and Microbiology, Vol 64, Iss 5, Pp 146-148 (2021)
institution DOAJ
collection DOAJ
language EN
topic abcb11
benign recurrent intrahepatic cholestasis
cholestasis
cirrhosis
jaundice
Pathology
RB1-214
Microbiology
QR1-502
spellingShingle abcb11
benign recurrent intrahepatic cholestasis
cholestasis
cirrhosis
jaundice
Pathology
RB1-214
Microbiology
QR1-502
K V Kalaranjini
Jinu A Glaxon
Sheela Vasudevan
M L Arunkumar
Benign recurrent intrahepatic cholestasis - 2 (BRIC-2)/ABCB11 deficiency in a young child – Report from a tertiary care center in South India
description ABCB11 deficiency, formerly benign recurrent intrahepatic cholestasis (BRIC) is a very rare hereditary disorder characterized by the recurrent and intermittent episodes of cholestasis, jaundice, and pruritus. We report the case of a 12-year-old boy presenting with recurrent episodes of jaundice and severe pruritis since childhood. An extensive workup was done to rule out all the possible etiologies. Liver biopsy was done and histopathology was consistent with intrahepatic cholestasis. Immunohistochemistry, enzyme studies, and genetic testing confirmed the diagnosis. The patient was treated with Ursodeoxycholicacid and is on regular follow-up. We report this case due to the rarity of the disease in South India and to highlight the importance of genetic testing, which is the gold standard for diagnosis as well as for the classification of the disease. These patients should be under regular follow-up as those with fibrosis progression are at a risk for cholangiocarcinoma and hepatocellular carcinoma.
format article
author K V Kalaranjini
Jinu A Glaxon
Sheela Vasudevan
M L Arunkumar
author_facet K V Kalaranjini
Jinu A Glaxon
Sheela Vasudevan
M L Arunkumar
author_sort K V Kalaranjini
title Benign recurrent intrahepatic cholestasis - 2 (BRIC-2)/ABCB11 deficiency in a young child – Report from a tertiary care center in South India
title_short Benign recurrent intrahepatic cholestasis - 2 (BRIC-2)/ABCB11 deficiency in a young child – Report from a tertiary care center in South India
title_full Benign recurrent intrahepatic cholestasis - 2 (BRIC-2)/ABCB11 deficiency in a young child – Report from a tertiary care center in South India
title_fullStr Benign recurrent intrahepatic cholestasis - 2 (BRIC-2)/ABCB11 deficiency in a young child – Report from a tertiary care center in South India
title_full_unstemmed Benign recurrent intrahepatic cholestasis - 2 (BRIC-2)/ABCB11 deficiency in a young child – Report from a tertiary care center in South India
title_sort benign recurrent intrahepatic cholestasis - 2 (bric-2)/abcb11 deficiency in a young child – report from a tertiary care center in south india
publisher Wolters Kluwer Medknow Publications
publishDate 2021
url https://doaj.org/article/0c72f70da8ce45fc8385a256521a78b7
work_keys_str_mv AT kvkalaranjini benignrecurrentintrahepaticcholestasis2bric2abcb11deficiencyinayoungchildreportfromatertiarycarecenterinsouthindia
AT jinuaglaxon benignrecurrentintrahepaticcholestasis2bric2abcb11deficiencyinayoungchildreportfromatertiarycarecenterinsouthindia
AT sheelavasudevan benignrecurrentintrahepaticcholestasis2bric2abcb11deficiencyinayoungchildreportfromatertiarycarecenterinsouthindia
AT mlarunkumar benignrecurrentintrahepaticcholestasis2bric2abcb11deficiencyinayoungchildreportfromatertiarycarecenterinsouthindia
_version_ 1718376657908137984